RSS Feed
Oculus, Bianco and Cel-Sci Oh My!: BioBuzz
Some Friday Fall tidbits from the biotech stock world.
10:53AM 11/06/09
Biotech Stock Mailbag: Poniard Predictions
Readers chime in on Poniard Pharmaceuticals, Chelsea Therapeutics, AMAG, Cel-Sci and Dendreon.
07:00AM 11/06/09
BioCryst Competition for IV Flu Drug: BioBuzz
U.S. government orders IV versions of two flu drugs to treat hospitalized patients.
06:29AM 11/06/09
BioCryst Winners and Losers: BioBuzz
Sorting out the latest salvo in the H1N1 investor war
02:32PM 11/05/09
Cel-Sci's Lawyer Speaks: BioBuzz
Cel-Sci's complaint avoids the central issue about its mystery South African partner.
10:40AM 11/05/09
BioCryst Ships Flu Drug to U.S. Government: BioBuzz
Initial order lower than expected but priced higher
08:03AM 11/05/09
Cel-Sci's South Africa Partner a Mystery
Little information is available about Byron Biopharma, which was incorporated just days before its marketing deal with Cel-Sci was announced.
10:23AM 11/04/09
Chelsea Just Got Riskier: BioBuzz
Change sought in a phase III trial adds risk and uncertainty.
10:41AM 11/03/09
Hemispherx Cops to Ampligen FDA Delay
Disclosure raises questions about the veracity of CEO's past statements.
07:47AM 11/03/09
Amylin Strikes First With Obesity Drug Deal: BioBuzz
Japanese drugmaker Takeda licenses worldwide rights to Amylin weight-loss pipeline.
12:09PM 11/02/09
Connect with TheStreet